Share
Great news yes. But they still need to get confirmation that they'll be paid for the previous tests right? Or else they won't get the big windfall cash payment. I think they'll need this to avoid another capital raise.
However they have around 15m in cash right now from memory.
The concentrate news from this announcement is that revenue will be paid for 40% of their USA tests under CMS moving forward.
Now they need to a) try and get paid for all their US tests not under CMS and b) increase adoption
Well done to all holders.
